Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancer Letters|September 15, 2005
In vitro toxicity evaluation in the development of new anticancer drugs-genistein glycosidesJoanna Popiołkiewicz, Krzysztof Polkowski, Janusz S Skierski, et al.
Current Computer-Aided Drug Design|March 7, 2017
Adsorption of Antifungal Drugs Inside Pristine and Functionalized Fullerenes and Nanotubes: DFT InvestigationTomasz Pieńko, Monika Grudzień, Przemysław Paweł Taciak, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 28, 2006
The usefulness of simple X-ray powder diffraction analysis for counterfeit control--the Viagra exampleJan K Maurin, Franciszek Pluciński, Aleksander P Mazurek, et al.
Acta Poloniae Pharmaceutica|May 17, 2016
NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART IIIDorota Marszałek, Anna Goldnik, Iwona Winiecka, et al.
Acta Poloniae Pharmaceutica|October 3, 2014
New renin inhibitors--stability and activity determination. Part IDorota Marszałek, Anna Goldnik, Aleksander P Mazurek, et al.
Acta Poloniae Pharmaceutica|October 24, 2013
Molecular properties impact on bioavailability of second generation triazoles antifungal agentsMonika K Grudzień, Karolina Pałka, Franciszek A Pluciński, et al.
Acta Poloniae Pharmaceutica|May 1, 2014
New renin inhibitors containing phenylalanylhistidyl-gamma-amino acid derivatives in P3 - P1' positionIwona Winiecka, Dorota Marszałek, Anna Goldnik, et al.
Acta Poloniae Pharmaceutica|April 11, 2018
IDENTIFICATION AND DETERMINATION OF RUPATADINE AND FEXOFENADINE BY DENSITOMETRIC METHODKrystyna Czerwinska, Elzbieta Wyszomirska, Elzbieta Kublin, et al.
Journal of Inclusion Phenomena and Macrocyclic Chemistry|January 17, 2014
Mass spectrometry and molecular modeling studies on the inclusion complexes between alendronate and β-cyclodextrinJoanna Biernacka, Katarzyna Betlejewska-Kielak, Janina Witowska-Jarosz, et al.
Acta Poloniae Pharmaceutica|October 24, 2013
Prediction of bioavailability of selected bisphosphonates using in silico methods towards categorization into a biopharmaceutical classification systemJoanna Biernacka, Katarzyna Betlejewska-Kielak, Ewa Kłosińska-Szmurło, et al.
Pageof 5